| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.36B | -1.9% |
| Cost of Revenue | $197.3M | +0.9% |
| R&D Expense | $68.9M | -7.1% |
| SG&A Expense | $421.1M | +4.2% |
| Operating Income | $132.6M | -33.3% |
| Interest Expense | $41.6M | +12.1% |
| Pre-tax Income | $75.0M | -42.8% |
| Income Tax | $24.1M | -58.3% |
| Net Income | $41.5M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $737.6M | +13.0% |
| Short-term Investments | $27.1M | -53.6% |
| Accounts Receivable | $337.7M | +10.8% |
| Current Assets | $1.19B | +9.8% |
| Total Assets | $3.47B | -1.8% |
| Current Liabilities | $431.8M | -0.1% |
| Long-term Debt | $1.00B | +0.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $320.0M | -4.9% |
| Capital Expenditures | $108.7M | +2.4% |
| Investing Cash Flow | -$127.4M | +42.3% |
| Financing Cash Flow | -$114.8M | +18.5% |
| Free Cash Flow | $211.2M | -8.3% |
| -34.9% |
| EPS (Basic) | $0.89 | -34.6% |
| EPS (Diluted) | $0.89 | -34.6% |
| Total Liabilities |
| $1.58B |
| -3.8% |
| Stockholders' Equity | $1.89B | +0.0% |